The Diabetes Care Devices (BRIC) Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favourable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.

Key Market Players:

Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375

The diabetes management mobile applications segment is projected to grow at the highest CAGR during the forecast period

Within the type segment, the market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The diabetes management mobile applications segment is projected to grow at the highest rate during the forecast period, driven by its convenience, simplicity of use, and utility in providing real-time insights regarding diabetic conditions to patients and healthcare professionals for integrated diabetes management.

China held the largest share in the diabetes care devices (BRIC) market.

China held the largest share in the diabetes care devices (BRIC) market in 2019. This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry. India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=375

The research report categorizes the market into the following segments and subsegments:

By Type

• Blood glucose monitoring systems
• Self-monitoring blood glucose monitoring systems
• Continuous glucose monitoring systems
• Test strips/Test papers
• Lancets/Lancing devices
• Insulin delivery devices
• Insulin pumps
• Insulin pens
• Insulin syringes and needles

By End User

• Hospitals specialty clinics
• Self home care

Recent Developments

• In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.
• In February 2020, Insulet signed a commercialization agreement with DexCom, Inc. (US) to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.
• In April 2020, Ypsomed (Switzerland) entered into a partnership with DexCom, Inc. (US) to integrate its mylife YpsoPump data with Dexcom’s G6 CGM sensors to form a hybrid closed-loop system.
• In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
• In December 2019, Eli Lilly and Company (US) announced a global commercialization agreement to integrate DexCom, Inc.’s products into Lilly's personalized diabetes management system, currently in development, to advance the treatment of diabetes.

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=375

 About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: [email protected]

Related Report:

Point-of-Care-Diagnostic-Market: https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html